CDK5R1
Basic information
Region (hg38): 17:32486993-32491253
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (16 variants)
- not_provided (4 variants)
- CDK5R1-related_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK5R1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003885.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 16 | 16 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 16 | 0 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CDK5R1 | protein_coding | protein_coding | ENST00000313401 | 1 | 4638 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.915 | 0.0846 | 125574 | 0 | 2 | 125576 | 0.00000796 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.91 | 115 | 189 | 0.608 | 0.0000124 | 1979 |
| Missense in Polyphen | 32 | 85.57 | 0.37396 | 903 | ||
| Synonymous | -0.635 | 102 | 94.2 | 1.08 | 0.00000680 | 663 |
| Loss of Function | 2.61 | 0 | 7.92 | 0.00 | 3.48e-7 | 91 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000546 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00000884 | 0.00000881 |
| Middle Eastern | 0.0000546 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: p35 is a neuron specific activator of CDK5. The complex p35/CDK5 is required for neurite outgrowth and cortical lamination. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling. Activator of TPKII. The complex p35/CDK5 participates in the regulation of the circadian clock by modulating the function of CLOCK protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer in association with altered stability and subcellular distribution. {ECO:0000269|PubMed:24235147}.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human);Cocaine addiction - Homo sapiens (human);Alzheimers Disease;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;ATM Signaling Network in Development and Disease;Developmental Biology;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;Signal Transduction;Gene expression (Transcription);regulation of ck1/cdk5 by type 1 glutamate receptors;lissencephaly gene (lis1) in neuronal migration and development;deregulation of cdk5 in alzheimers disease;phosphorylation of mek1 by cdk5/p35 down regulates the map kinase pathway;rac1 cell motility signaling pathway;Generic Transcription Pathway;RNA Polymerase II Transcription;Activated NTRK2 signals through CDK5;Signaling by NTRK2 (TRKB);Signaling by NTRKs;Glucocorticoid receptor regulatory network;Semaphorin interactions;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Axon guidance;CRMPs in Sema3A signaling;Signaling by Receptor Tyrosine Kinases;Reelin signaling pathway;Trk receptor signaling mediated by the MAPK pathway;Lissencephaly gene (LIS1) in neuronal migration and development
(Consensus)
Recessive Scores
- pRec
- 0.184
Intolerance Scores
- loftool
- 0.0469
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 42.88
Haploinsufficiency Scores
- pHI
- 0.545
- hipred
- Y
- hipred_score
- 0.837
- ghis
- 0.651
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.923
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Medium |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdk5r1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Zebrafish Information Network
- Gene name
- cdk5r1a
- Affected structure
- bile ductule
- Phenotype tag
- abnormal
- Phenotype quality
- decreased branchiness
Gene ontology
- Biological process
- regulation of cyclin-dependent protein serine/threonine kinase activity;microtubule cytoskeleton organization;neuron migration;neuron cell-cell adhesion;G protein-coupled acetylcholine receptor signaling pathway;axon guidance;axonal fasciculation;brain development;cell population proliferation;embryo development ending in birth or egg hatching;regulation of macroautophagy;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;cerebellum development;superior olivary nucleus maturation;hippocampus development;layer formation in cerebral cortex;neuron differentiation;negative regulation of axon extension;positive regulation of microtubule polymerization;neuron projection development;regulation of actin cytoskeleton organization;ionotropic glutamate receptor signaling pathway;serine phosphorylation of STAT protein;positive regulation of neuron apoptotic process;regulation of neuron differentiation;negative regulation of transcription, DNA-templated;ephrin receptor signaling pathway;rhythmic process;regulation of dendritic spine morphogenesis;positive regulation of cell cycle arrest;positive regulation of protein serine/threonine kinase activity;positive regulation of protein targeting to membrane;regulation of synaptic vesicle cycle
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;microtubule;plasma membrane;postsynaptic density;membrane;protein kinase 5 complex;axon;dendrite;growth cone;neuromuscular junction;neuron projection;neuronal cell body;dendritic spine;intracellular membrane-bounded organelle;contractile fiber;perinuclear region of cytoplasm;presynapse
- Molecular function
- protease binding;protein kinase activity;calcium ion binding;protein binding;kinase activity;protein kinase binding;ionotropic glutamate receptor binding;alpha-tubulin binding;protein serine/threonine kinase activator activity;cadherin binding;ephrin receptor binding;beta-tubulin binding;actin filament binding;cyclin-dependent protein serine/threonine kinase activator activity